Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Pharmacodynamic efficacy, clinical safety, and outcomes after prolonged platelet glycoprotein iib/iiia receptor blockade with oral xemilofiban - results of a multicenter, placebo-controlled, randomized trial

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Kereiakes, D. J.
  • Kleiman, N. S.
  • Ferguson, J. J.
  • Masud, Z.
  • Broderick, T. M.
  • Abbottsmith, C. W.
  • Runyon, J. P.
  • Anderson, L. C.
  • Anders, R. J.
  • Dreiling, R. J.
  • Hantsbarger, G. L.
  • Bryzinski, B.
  • Topol, Eric

publication date

  • September 1998

journal

  • Circulation  Journal

subject areas

  • Administration, Oral
  • Adult
  • Aged
  • Aged, 80 and over
  • Benzamidines
  • Blood Transfusion
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Middle Aged
  • Platelet Aggregation
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Treatment Outcome
scroll to property group menus

Research

keywords

  • glycoproteins
  • platelets
  • receptors
  • thrombosis
  • xemilofiban
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0009-7322

PubMed ID

  • 9751674
scroll to property group menus

Additional Document Info

start page

  • 1268

end page

  • 1278

volume

  • 98

issue

  • 13

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support